MI-3
MI-3 (Menin-MLL inhibitor 3) is a potent and high affinity menin-MLL inhibitor with an IC50 of 648 nM and a Kd of 201 nM[1].
Product Specifications
CAS Number
1271738-59-0
Product Name Alternative
Menin-MLL inhibitor 3
UNSPSC
12352005
Target
Apoptosis; Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/MI-3.html
Purity
99.58
Solubility
DMSO : 8.33 mg/mL (ultrasonic)
Smiles
CC(C)C1=CC2=C(N3CCN(C4=NCC(C)(C)S4)CC3)N=CN=C2S1
Molecular Formula
C18H25N5S2
Molecular Weight
375.55
References & Citations
[1]Grembecka J, et al. Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. Nature Chemical Biology (2012), 8 (3), 277-284.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15146933 1 Vial
Lentiviral human CEP295 shRNA (UAS) - Lentiviral human CEP295 shRNA (UAS) (25)
Sign In for Pricing
View Details